Evidence map›Paper›PMID 27123465›Full record

ArticleJournal of immunology research2016

Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.

Federica Pulvirenti, Roberta Zuntini, Cinzia Milito, Fernando Specchia, Giuseppe Spadaro, Maria Giovanna Danieli, Andrea Pession, Isabella Quinti, Simona Ferrari

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Re-evaluation of the contribution ofJournal of human immunity · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Innate Mechanisms in Selective IgA Deficiency.Frontiers in immunology · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Federica PulvirentiDepartment of Molecular Medicine, Sapienza Medical University, Viale Università 37, 00185 Rome, Italy.
Roberta ZuntiniDepartment of Medical Genetics, Policlinico S. Orsola-Malpighi, Medical University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Cinzia MilitoDepartment of Molecular Medicine, Sapienza Medical University, Viale Università 37, 00185 Rome, Italy.
Fernando SpecchiaDepartment of Pediatrics, Policlinico S. Orsola-Malpighi, Medical University of Bologna University of Bologna, Via Pietro Albertoni 15, 10138 Bologna, Italy.
Giuseppe SpadaroDepartment of Clinical Medicine and Surgery, Medical University of Naples Federico II, Corso Umberto I 40, 80138 Naples, Italy.
Maria Giovanna DanieliDepartment of Medical and Molecular Sciences, Torrette Hospital, Medical University of Ancona, Via Conca 71, 60126 Torrette, Italy.
Andrea PessionDepartment of Pediatrics, Policlinico S. Orsola-Malpighi, Medical University of Bologna University of Bologna, Via Pietro Albertoni 15, 10138 Bologna, Italy.
Isabella QuintiDepartment of Molecular Medicine, Sapienza Medical University, Viale Università 37, 00185 Rome, Italy.
Simona FerrariDepartment of Medical Genetics, Policlinico S. Orsola-Malpighi, Medical University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Sapienza University of Rome · ITPoliclinico S.Orsola-Malpighi · ITUniversity of Bologna · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed the prevalence of TNFRSF13B mutations and the clinical correlates in an Italian cohort of 189 CVID, 67 IgAD patients, and 330 healthy controls to substantiate the role of TACI genetic testing in diagnostic workup. We found that 11% of CVID and 13% of IgAD carried at least one mutated TNFRSF13B allele. Seven per cent of CVID had monoallelic-mutations and 4% had biallelic-mutations. The frequency of C104R monoallelic-mutations was not higher than that found in healthy controls. Biallelic-mutations were exclusively found in CVID. CVID patients carrying monoallelic-mutations had an increased prevalence of lymphadenopathy, granulomata, and autoimmune cytopenias. CVID carrying biallelic-mutations had a low prevalence of autoimmunity in comparison with TACI wild-type CVID. Moreover, biallelic-mutated CVID had higher frequency of switched memory B-cells and higher IgM and IgA antibodies to polysaccharide antigens than TACI wild-type and monoallelic-mutated CVID. TACI-mutated IgAD patients had only monoallelic-mutations and did not display clinical difference from IgAD wild-type patients. In conclusion, TNFRSF13B genetic screening of antibody deficiencies may allow the identification of mutational patterns. However, as with counseling for risk assessment, geneticists should be aware that the interpretation of genetic testing for TACI mutations is difficult and the potential impact on clinical management is still limited.

Indexed as

Polymorphism, GeneticAdultAgedAllelesAutoantibodiesAutoimmunityB-LymphocytesCase-Control StudiesFemaleGene ExpressionGene FrequencyGenetic CounselingGenetic TestingHumansImmunoglobulin AImmunoglobulin MAutoantibodiesImmunoglobulin AImmunoglobulin MTNFRSF13B protein, humanTransmembrane Activator and CAML Interactor Protein

Identifiers

PMID27123465
PMCPMC4829724
OpenAlexW2312595326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.